Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia

Published:2017-08-18 Issue:3 Volume:32 Page:606-615
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Toft N,Birgens H,Abrahamsson J,Griškevičius L,Hallböök H,Heyman M,Klausen T W,Jónsson ÓG,Palk K,Pruunsild K,Quist-Paulsen P,Vaitkeviciene G,Vettenranta K,Åsberg A,Frandsen T L,Marquart H V,Madsen H O,Norén-Nyström U,Schmiegelow K

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2017265.pdf

Reference43 articles.

1. Pui CH, Yang JJ, Hunger SP, Pieters R, Schrappe M, Biondi A et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol 2015; 33: 2938–2948.

2. Toft N, Schmiegelow K, Klausen TW, Birgens H . Adult acute lymphoblastic leukaemia in Denmark. A national population-based retrospective study on acute lymphoblastic leukaemia in Denmark 1998–2008. Br J Haematol 2012; 157: 97–104.

3. Stock W, Johnson JL, Stone RM, Kolitz JE, Powell BL, Wetzler M et al. Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802. Cancer 2013; 119: 90–98.

4. Schmiegelow K, Forestier E, Hellebostad M, Heyman M, Kristinsson J, Soderhall S et al. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia 2010; 24: 345–354.

5. Goldstone AH, Richards SM, Lazarus HM, Tallman MS, Buck G, Fielding AK et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008; 111: 1827–1833.

Cited by 317 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants of survival after first relapse of acute lymphoblastic leukemia: a Children’s Oncology Group study;Leukemia;2024-09-11

2. Immunophenotypic Characteristics and Cytogenetic Analysis of Adolescent and Young Adult B-Cell Acute Lymphoblastic Leukemia: Correlations With Clinicopathological Parameters;Cureus;2024-09-05

3. Allogeneic stem cell transplant with TBI-based myeloablative conditioning in adolescents and young adults with Philadelphia chromosome-negative ALL treated with pediatric protocols;Leukemia Research;2024-09

4. A Finnish nationwide register‐based study shows a further 50% decline in already low child mortality;Acta Paediatrica;2024-08-21

5. Intestinal mucositis, systemic inflammation and bloodstream infections following high‐dose methotrexate treatment in childhood acute lymphoblastic leukaemia: Comparison between the NOPHO ALL 2008 protocol and the ALLTogether1 protocol;International Journal of Cancer;2024-08-16